BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 19222175)

  • 1. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
    Paulitschke V; Kunstfeld R; Mohr T; Slany A; Micksche M; Drach J; Zielinski C; Pehamberger H; Gerner C
    J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.
    Piersma SR; Fiedler U; Span S; Lingnau A; Pham TV; Hoffmann S; Kubbutat MH; Jiménez CR
    J Proteome Res; 2010 Apr; 9(4):1913-22. PubMed ID: 20085282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B.
    Slany A; Haudek VJ; Zwickl H; Gundacker NC; Grusch M; Weiss TS; Seir K; Rodgarkia-Dara C; Hellerbrand C; Gerner C
    J Proteome Res; 2010 Jan; 9(1):6-21. PubMed ID: 19678649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
    Wimmer H; Gundacker NC; Griss J; Haudek VJ; Stättner S; Mohr T; Zwickl H; Paulitschke V; Baron DM; Trittner W; Kubicek M; Bayer E; Slany A; Gerner C
    Electrophoresis; 2009 Jun; 30(12):2076-89. PubMed ID: 19582709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel technique to specifically analyze the secretome of cells and tissues.
    Zwickl H; Traxler E; Staettner S; Parzefall W; Grasl-Kraupp B; Karner J; Schulte-Hermann R; Gerner C
    Electrophoresis; 2005 Jul; 26(14):2779-85. PubMed ID: 15966010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
    Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells.
    Chenau J; Michelland S; de Fraipont F; Josserand V; Coll JL; Favrot MC; Seve M
    J Proteome Res; 2009 Oct; 8(10):4579-91. PubMed ID: 19639960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scanning the cell surface proteome of cancer cells and identification of metastasis-associated proteins using a subtractive immunization strategy.
    Rasmussen N; Ditzel HJ
    J Proteome Res; 2009 Nov; 8(11):5048-59. PubMed ID: 19764822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
    He Y; Wu X; Liu X; Yan G; Xu C
    J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative proteomic analysis of matched primary and metastatic melanoma cell lines.
    Al-Ghoul M; Brück TB; Lauer-Fields JL; Asirvatham VS; Zapata C; Kerr RG; Fields GB
    J Proteome Res; 2008 Sep; 7(9):4107-18. PubMed ID: 18698805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation.
    Sarvaiya HA; Yoon JH; Lazar IM
    Rapid Commun Mass Spectrom; 2006; 20(20):3039-55. PubMed ID: 16986208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
    Pardo M; García A; Thomas B; Piñeiro A; Akoulitchev A; Dwek RA; Zitzmann N
    Proteomics; 2005 Dec; 5(18):4980-93. PubMed ID: 16267820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage.
    Baruthio F; Quadroni M; Rüegg C; Mariotti A
    Proteomics; 2008 Nov; 8(22):4733-47. PubMed ID: 18942674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
    Escobar MA; Hoelz DJ; Sandoval JA; Hickey RJ; Grosfeld JL; Malkas LH
    J Pediatr Surg; 2005 Feb; 40(2):349-58. PubMed ID: 15750928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.